Literature DB >> 7987312

Characterization of an 800 kb region at 3p22-p21.3 that was homozygously deleted in a lung cancer cell line.

Y Murata1, M Tamari, T Takahashi, Y Horio, K Hibi, S Yokoyama, J Inazawa, K Yamakawa, A Ogawa, T Takahashi.   

Abstract

We have characterized a homozygous deletion at 3p22-p21.3 found in a lung cancer cell line ACC-LC-5. Three yeast artificial chromosomes (YACs) were isolated from a YAC library by hybridization with two cosmid probes (cCI3-1994 and cCI3-1999) representing loci that were homozygously deleted in five lung cancer cell lines. Cloning both ends of the region deleted in the cell line ACC-LC-5 revealed the deletion was an interstitial deletion within the chromosomal arm. A cosmid contig map covering the entire region corresponding to the homozygous deletion was constructed by means of Southern hybridizations. From these results and analyses by pulsed-field gel electrophoresis, this interstitial deletion on chromosome 3p22-21.3 in this cell line was estimated to be nearly 800 kb long and is smallest among five cell lines containing the homozygous deletion. The cosmid clones representing this region will contribute important new resources for isolating the putative tumor suppressor gene(s) on chromosome 3p22-21.3.

Entities:  

Mesh:

Year:  1994        PMID: 7987312     DOI: 10.1093/hmg/3.8.1341

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  7 in total

1.  NotI flanking sequences: a tool for gene discovery and verification of the human genome.

Authors:  Alexey S Kutsenko; Rinat Z Gizatullin; Ali N Al-Amin; Fuli Wang; Sergei M Kvasha; Raf M Podowski; Yuri G Matushkin; Anita Gyanchandani; Olga V Muravenko; Viktor G Levitsky; Nikolay A Kolchanov; Alexei I Protopopov; Vladimir I Kashuba; Lev L Kisselev; Wyeth Wasserman; Claes Wahlestedt; Eugene R Zabarovsky
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

2.  Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.

Authors:  Y Yang; M Kost-Alimova; S Ingvarsson; Q Qianhui; H Kiss; A Szeles; I Kholodnyuk; A Cuthbert; G Klein; S Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

3.  Exclusion of epidermal growth factor and high-resolution physical mapping across the Rieger syndrome locus.

Authors:  E V Semina; N A Datson; N J Leysens; B U Zabel; J C Carey; G I Bell; P Bitoun; C Lindgren; T Stevenson; R R Frants; G van Ommen; J C Murray
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

4.  Origin recognition complex 1 regulates phospholipase Cδ1 to inhibit cell proliferation, migration and epithelial-mesenchymal transition in lung adenocarcinoma.

Authors:  Yao Jian; Qing Qiao; Juanjuan Tang; Xiaobing Qin
Journal:  Oncol Lett       Date:  2022-06-10       Impact factor: 3.111

5.  Isolation of a cosmid clone corresponding to an inv(21) breakpoint of a patient with transient abnormal myelopoiesis.

Authors:  T Ohta; M Nakano; T Tsujita; K Abe; K Osoegawa; T Yamagata; K Yoshiura; Y Jinno; E Soeda; Y Nakamura; N Niikawa
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

6.  Yeast artificial chromosome cloning of the beta-catenin locus on human chromosome 3p21-22.

Authors:  A Bailey; A L Norris; J P Leek; P M Clissold; I M Carr; D J Ogilvie; J F Morrison; D M Meredith; A F Markham
Journal:  Chromosome Res       Date:  1995-05       Impact factor: 5.239

7.  Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.

Authors:  Vitaly I Loginov; Alexey A Dmitriev; Vera N Senchenko; Irina V Pronina; Dmitry S Khodyrev; Anna V Kudryavtseva; George S Krasnov; Ganna V Gerashchenko; Larisa I Chashchina; Tatiana P Kazubskaya; Tatiana T Kondratieva; Michael I Lerman; Debora Angeloni; Eleonora A Braga; Vladimir I Kashuba
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.